20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11526 | DPP-IV-IN-2 | H-Lys(4-nitro-Z)-pyrrolidide | DPP-4 |
DPP-IV-IN-2 (H-Lys(4-nitro-Z)-pyrrolidide) is an inhibitor of both DP8/9 and dipeptidyl peptidase IV (IC50s: 0.1 and 0.95 μM). | |||
TN1418 | Azaleatin | DPP-4 | |
Azaleatin is a natural product from Rhododendron simsii. Azaleatin is a dipeptidyl peptidase-IV inhibitor. Azaleatin can be used for type-2 diabetes and obesity studies. | |||
T7369L | Gemigliptin Tartrate(911637-19-9 free base) | LC15-0444 tartrate | Proteasome , DPP-4 |
Gemigliptin Tartrate (LC15-0444 tartrate) is a highly selective, reversible and competitive inhibitor of dipeptidyl peptidase-4 (DPP-4). It has an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate exhibit... | |||
T6192 | Alogliptin | SYR-322 | Ferroptosis , Proteasome , DPP-4 |
Alogliptin (SYR-322)(SYR-322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10, 000-fold selectivity over DPP-8 and DPP-9. | |||
T12710 | Retagliptin Phosphate | SP 2086 | Proteasome , DPP-4 |
Retagliptin Phosphate (SP 2086) is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes. | |||
T7133 | Anagliptin | SK-0403 | Proteasome , DPP-4 |
Anagliptin (SK-0403) is a potent Inhibitor of DPP-4(IC50 of 3.8 nM), for the treatment of type 2 diabetes mellitus. | |||
T2401 | Alogliptin Benzoate | SYR 322,Alogliptin(SYR-322)benzoate | Ferroptosis , Proteasome , DPP-4 |
Alogliptin Benzoate (SYR 322)(SYR 322), an effective and specific DPP-4 inhibitor (IC50<10 nM), exhibits greater than 10, 000-fold selectivity over DPP-8/9. Alogliptin may inhibit inflammatory responses by preventing the... | |||
T6203 | Saxagliptin | BMS-477118,Onglyza | Proteasome , DPP-4 |
Saxagliptin (BMS-477118) is a selective and reversible DPP4 inhibitor with IC50 of 26 nM. | |||
T0178 | Saxagliptin hydrate | Onglyza hydrate,BMS-477118 hydrate | Proteasome , DPP-4 |
Saxagliptin hydrate (Onglyza hydrate) is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM). | |||
T29019 | TS-021 | TS021,TS 021,TS-021 Free | DPP-4 |
TS-021 is a selective dipeptidyl peptidase 4 (DPP-4) inhibitor with antidiabetic activity for the study of type 2 diabetes. | |||
T7369 | Gemigliptin | LC15-0444 | Proteasome , DPP-4 |
Gemigliptin (LC15-0444) is a potent dipeptidyl peptidase-4 (DPP-4) inhibitor(KD : 7.25 nM.) | |||
T16838 | Saikogenin A | Proteasome , DPP-4 | |
Saikogenin A is a dipeptidyl peptidase-4 inhibitor. | |||
T23358 | Sitagliptin phosphate | Januvia,MK-0431 phosphate,Sitagliptin (phosphate) | DPP-4 , Autophagy |
Sitagliptin phosphate (MK-0431 phosphate) is a dipeptidyl peptidase-4 (DPP4) inhibitor. | |||
T0191 | Linagliptin | BI 1356 | Ferroptosis , Proteasome , DPP-4 , Autophagy |
Linagliptin (BI 1356) is a potent, orally bioavailable dihydropurinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. | |||
T2296 | Trelagliptin succinate | SYR-472 succinate,SYR472 | Proteasome , DPP-4 |
Trelagliptin succinate (SYR-472 succinate) is a long-acting inhibitor of dipeptidyl peptidase-4 (DPP-4), being developed for the treatment of type 2 diabetes (T2D). | |||
T6999 | Teneligliptin hydrobromide | Teneligliptin hydrobromide anhydrous,MP-513 (hydrobromide) | Others , Proteasome , DPP-4 |
Teneligliptin hydrobromide (MP-513 (hydrobromide)) is a novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor; competitively inhibited human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50 ... | |||
T68053 | Denagliptin | GW823093 | DPP-4 |
Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine Ü metabolic diseases and can be used in the study of type 2 diabetes. | |||
T1502 | Vildagliptin | NVP-LAF 237,LAF237 | Apoptosis , Ferroptosis , Proteasome , DPP-4 |
Vildagliptin (LAF237) is a cyanopyrrolidine-based, orally bioavailable inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. Vildagliptin's cyano moiety undergoes hydrolysis and this inactive metabolit... | |||
T0242 | Sitagliptin | MK0431 | Proteasome , DPP-4 , Autophagy |
Sitagliptin (MK0431), a new oral hypoglycemic (anti-diabetic drug), is a new dipeptidyl peptidase-4 (DPP-4) inhibitor. This enzyme-inhibiting drug is used either alone or in combination with metformin or thiazolidinedion... | |||
T26941 | Camegliptin | RO-4876904-001,R1579,RG1579,RO-4876904,R-1579,RG-1579 | |
Cameglipti, a dipeptidyl peptidase IV (DPP-4) inhibitor, is used potentially for the treatment of type 2 diabetes. |